Company / Operating Cash Flow per Share
Intellia Therapeutics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.87
FY2025
5-year range
-$4.52 / -$3.40
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
#152 of 155
Health Care
What the data says
Among 155 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 2% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.52 in FY2023 to $1.62 in FY2016.
Based on SEC 10-K filings.
-3.87 in FY2025.
Improved from $-4.52 to $-3.87 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 155This company -$3.87 Sector average $6.77
▼
-157.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 3.1% year-over-year.
- Ranks #152 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.87 | -3.1% |
| FY2024 | -$3.75 | +17.1% |
| FY2023 | -$4.52 | -1.1% |
| FY2022 | -$4.47 | -31.7% |
| FY2021 | -$3.40 | -241.7% |
| FY2020 | -$0.99 | +56.4% |
| FY2019 | -$2.28 | -58.0% |
| FY2018 | -$1.45 | +20.3% |
| FY2017 | -$1.81 | -211.6% |
| FY2016 | $1.62 | +122.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026